LFCR
Lifecore Biomedical Inc.
4.20$
-2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 26.9% | 25.2% | 22.7% | 24.0% | 25.6% | 29.0% | 29.5% | 41.9% | 42.5% | 31.9% | 35.8% | 35.4% | |
| 4.1% | 2.9% | 1.5% | 0.7% | 0.2% | 0.1% | 0.2% | 0.6% | 0.4% | 3.3% | 3.5% | 7.5% | |
| 4.1% | 2.9% | 1.5% | 0.7% | 0.2% | 0.1% | 0.2% | 0.6% | 0.4% | 3.3% | 3.5% | 7.5% | |
| 13.5% | 13.5% | 12.8% | 13.3% | 13.4% | 14.1% | 8.2% | 16.3% | 13.9% | 12.3% | 18.2% | 14.6% | |
| 7.2% | 7.4% | 7.1% | 7.9% | 10.4% | 12.3% | 12.5% | 22.6% | 13.1% | 15.7% | 13.5% | 12.5% | |
| – | – | – | – | 38.5% | 40.2% | 27.3% | 47.1% | 49.0% | – | – | – | |
| 14.3% | 14.4% | 15.3% | 13.5% | 14.8% | 12.8% | 6.7% | 4.7% | 5.1% | 5.5% | 5.8% | 6.0% | |
| 16.2% | 6.2% | 6.4% | 5.4% | 8.7% | 7.0% | 5.1% | 5.3% | 1.5% | 1.7% | 1.8% | 1.8% | |
| 36.5% | 38.2% | 36.3% | 37.6% | 48.0% | 57.3% | 59.7% | 63.4% | 68.0% | 95.5% | 99.4% | 106.1% | |
| 16.2% | 16.5% | 14.4% | 21.8% | 26.4% | 30.4% | 20.3% | 26.8% | 64.3% | 15.3% | 12.6% | 10.2% | |
| 2.4% | 3.3% | 2.2% | 7.9% | 11.9% | 17.3% | 6.1% | 15.5% | 51.9% | 1.9% | 1.6% | 0.6% | |
| 10.1% | 9.0% | 6.9% | 8.6% | 10.4% | 9.5% | 3.2% | 5.4% | 4.7% | 6.4% | 3.4% | 2.5% | |
| – | – | – | – | 16.8% | 18.7% | 32.8% | 33.1% | 36.9% | 47.5% | 53.1% | 58.4% | |
| 63.0% | 61.4% | 63.3% | 62.4% | 52.0% | 42.7% | 40.3% | 36.6% | 32.0% | 4.5% | 0.6% | -6.1% | |
| 24.6% | 21.4% | 23.6% | 27.0% | 21.1% | 13.2% | 7.7% | -19.9% | -28.7% | -65.6% | -85.8% | -96.1% | |
| 7.9% | 7.9% | 7.7% | 6.9% | 5.5% | 5.4% | 5.8% | 10.0% | 10.7% | 14.4% | 14.5% | 16.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.